MXPA04001876A - Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis. - Google Patents

Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis.

Info

Publication number
MXPA04001876A
MXPA04001876A MXPA04001876A MXPA04001876A MXPA04001876A MX PA04001876 A MXPA04001876 A MX PA04001876A MX PA04001876 A MXPA04001876 A MX PA04001876A MX PA04001876 A MXPA04001876 A MX PA04001876A MX PA04001876 A MXPA04001876 A MX PA04001876A
Authority
MX
Mexico
Prior art keywords
fucans
psoriasis
arthritis
adhesions
treatment
Prior art date
Application number
MXPA04001876A
Other languages
English (en)
Inventor
K Jackson John
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Publication of MXPA04001876A publication Critical patent/MXPA04001876A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Abstract

Composiciones, metodos y similares que comprenden fucanos tales como fucoidanos para tratar adhesiones quirurgicas, artritis y psoriasis.
MXPA04001876A 2001-08-29 2002-08-29 Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis. MXPA04001876A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31536201P 2001-08-29 2001-08-29
PCT/CA2002/001337 WO2003018033A1 (en) 2001-08-29 2002-08-29 Use of fucans in the treatment of adhesions, arthritis and psoriasis

Publications (1)

Publication Number Publication Date
MXPA04001876A true MXPA04001876A (es) 2004-06-15

Family

ID=23224048

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001876A MXPA04001876A (es) 2001-08-29 2002-08-29 Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis.

Country Status (16)

Country Link
US (3) US6812220B2 (es)
EP (1) EP1420801B1 (es)
JP (2) JP4758063B2 (es)
KR (2) KR100910246B1 (es)
CN (2) CN1319540C (es)
AT (1) ATE376835T1 (es)
AU (1) AU2002325113B2 (es)
CA (1) CA2458853C (es)
DE (1) DE60223262T2 (es)
DK (1) DK1420801T3 (es)
ES (1) ES2295386T3 (es)
HK (1) HK1066482A1 (es)
MX (1) MXPA04001876A (es)
NZ (2) NZ547609A (es)
PT (1) PT1420801E (es)
WO (1) WO2003018033A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632456B1 (en) * 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
JP2006511475A (ja) * 2002-09-18 2006-04-06 トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア 脈絡膜新生血管症の抑制方法
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
JP4768440B2 (ja) 2003-03-06 2011-09-07 セルミド リミテッド 開腹手術後の癒着の予防剤
WO2004105737A2 (en) * 2003-05-30 2004-12-09 Arc Pharmaceuticals, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
WO2005089800A1 (ja) * 2004-03-17 2005-09-29 Locomogene, Inc. hsHRD3を含む医薬組成物
EP1773943B1 (en) * 2004-07-09 2016-03-09 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
PL1809303T3 (pl) * 2004-09-23 2019-11-29 Arc Medical Devices Inc Kompozycje farmaceutyczne i sposoby dotyczące hamowania zrostów włóknistych lub stanów zapalnych przy użyciu fukanów o niskiej zawartości siarczanów
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
SI1848431T1 (sl) 2005-02-09 2016-05-31 Santen Pharmaceutical Co., Ltd. Tekoče formulacije za zdravljenje bolezni ali stanj
MX2007009944A (es) * 2005-02-16 2007-10-10 Md Bioalpha Co Ltd Composicion farmaceutica para el tratamiento o prevencion de enfermedades que implican obesidad, diabetes, sindrome metabolico, enfermedades neurodegenerativas y enfermedades por disfuncion mitocondrial.
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US7666448B2 (en) * 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
JP2008536865A (ja) 2005-04-15 2008-09-11 アルバート・アインシユタイン・カレツジ・オブ・メデイシン・オブ・イエシバ・ユニバーシテイ 抗ｅｇｆｒ療法に二次的な皮疹の予防および処置のためのビタミンｋ
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
WO2007028256A2 (en) * 2005-09-09 2007-03-15 Les Biotechnologies Oceanova Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
JP5528708B2 (ja) 2006-02-09 2014-06-25 参天製薬株式会社 安定な製剤ならびにそれらを調製および使用する方法
FR2897538B1 (fr) 2006-02-23 2008-05-02 Univ Paris Descartes Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
JP4814677B2 (ja) * 2006-03-31 2011-11-16 株式会社荏原製作所 基板保持装置および研磨装置
US9428582B2 (en) 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
ES2585483T3 (es) 2008-02-13 2016-10-06 The Cleveland Clinic Foundation Mejora molecular de la matriz extracelular y métodos de uso
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
EP2300042A4 (en) 2008-04-30 2012-05-02 Cleveland Clinic Foundation COMPOSITIONS AND METHODS FOR TREATING URINARY INCONTINENCE
JP5819189B2 (ja) * 2009-03-25 2015-11-18 国立大学法人鳥取大学 軟骨生成促進剤および軟骨損傷由来疾病の予防治療剤
JO3676B1 (ar) 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
KR101528265B1 (ko) * 2010-04-16 2015-06-11 코웨이 주식회사 베타-라파콘을 유효성분으로 포함하는 주름개선용 화장료 조성물
EP2734213B1 (en) * 2011-07-19 2018-06-06 Baxalta GmbH Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
CN107580497A (zh) * 2015-02-16 2018-01-12 克桑蒂亚尔 用于预防或治疗皮肤病症的组合物
SI3448421T1 (sl) 2016-04-29 2022-02-28 The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Postopki in sestavki za preprečevanje in zdravljenje kirurških adhezij
CN112513104B (zh) * 2018-07-27 2023-06-13 Arc医疗器械股份有限公司 用于治疗纤维性粘连的高度硫酸酯化的褐藻糖胶
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971848A (en) * 1970-12-21 1976-07-27 Kimitsu Chemical Laboratory Co. Ltd. Lubricating composition for mucosa or epidermis
EP0293826A3 (en) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
JPS6431707A (en) 1987-07-28 1989-02-02 Nikko Chemicals Dermal agent for external use
JPH0714850B2 (ja) 1987-09-29 1995-02-22 喜郎 板谷 化粧料
JPH01313433A (ja) 1988-06-13 1989-12-18 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
JP2853165B2 (ja) * 1989-05-29 1999-02-03 味の素株式会社 体組織癒着防止膜
FR2648463B1 (fr) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention
US6096722A (en) * 1990-08-14 2000-08-01 Isis Pharmaceuticals Inc. Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP3403496B2 (ja) 1993-09-24 2003-05-06 株式会社ヤクルト本社 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤
JP3545789B2 (ja) * 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内癒着防止剤
FR2772618B1 (fr) * 1997-12-18 2000-02-18 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
AU6285999A (en) * 1998-10-02 2000-04-26 Genzyme Corporation Prevention of adhesions
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP2001052309A (ja) 1999-08-06 2001-02-23 Alps Electric Co Ltd 薄膜磁気ヘッドおよびその製造方法
SE0001631D0 (sv) * 2000-05-04 2000-05-04 Sahltech Ab New use

Also Published As

Publication number Publication date
JP2009280597A (ja) 2009-12-03
CN1547478A (zh) 2004-11-17
EP1420801B1 (en) 2007-10-31
KR20040032992A (ko) 2004-04-17
WO2003018033A1 (en) 2003-03-06
CA2458853A1 (en) 2003-03-06
HK1066482A1 (en) 2005-03-24
PT1420801E (pt) 2008-01-17
US7163930B2 (en) 2007-01-16
US20050119216A1 (en) 2005-06-02
KR20090019926A (ko) 2009-02-25
US6812220B2 (en) 2004-11-02
CN1319540C (zh) 2007-06-06
DE60223262T2 (de) 2008-08-14
KR100910246B1 (ko) 2009-07-31
DK1420801T3 (da) 2008-03-03
ES2295386T3 (es) 2008-04-16
US20030064958A1 (en) 2003-04-03
DE60223262D1 (de) 2007-12-13
CN101028283A (zh) 2007-09-05
EP1420801A1 (en) 2004-05-26
JP4758063B2 (ja) 2011-08-24
CA2458853C (en) 2010-10-19
JP2005508893A (ja) 2005-04-07
ATE376835T1 (de) 2007-11-15
NZ547609A (en) 2008-07-31
AU2002325113B2 (en) 2006-10-26
NZ532015A (en) 2006-12-22
US20050074496A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
PT1420801E (pt) Utilização de fucanos no tratamento de adesões, artrite e psoríase
WO2004052280A3 (en) Anti-angiogenic compounds and their use in cancer treatment
GEP20063805B (en) Alkyne-Arylnaphthyridin-4-one as Phosphodiesterase-4 Inhibitors
IL172773A (en) Formulations for the treatment of arthritis conditions
MY137757A (en) Therapeutic treatment
MXPA05010819A (es) Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
WO2004030627A3 (en) Synergistic methods and compositions for treating cancer
TW200510416A (en) P38 inhibitors and methods of use thereof
HK1076052A1 (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
HK1096392A1 (en) Substituted heterocycles
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
AU5173501A (en) Polyamine analogues as cytotoxic agents
AU2001246600A1 (en) Use of comt inhibitors as analgesics
EP1383516A4 (en) CO-ADMINISTRATION OF A POLYSACCHARIDE WITH A CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER
GEP20053590B (en) Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors
GB0215526D0 (en) Anticancer compounds
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
BR0111785A (pt) Composições e métodos para tratamento de candidìase
PT1303520E (pt) Compostos terapêuticos e métodos
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
PL367401A1 (en) Utilization of buprenorphine in urinary incontinence therapy
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer

Legal Events

Date Code Title Description
FG Grant or registration